XML 24 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
MCPS [Member]
 [1]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2017 $ 18,745 $ 54 $ 3,631 $ 23,479 $ (3,803) $ (1,853) $ (4,149) $ 17,359 $ 1,386
Beginning balance, shares at Dec. 31, 2017   1,124              
Cumulative effect of new accounting standard [2]         (5) 5      
Net income (loss) (2,472)       (2,150)     (2,150) (322)
Other comprehensive income (loss) (585)         (611)   (611) 26
Issuance of Shares, value (52) [3] $ 2 [3] (3,880) 3,826 [3]          
Issuance of Shares, shares [3]   72              
Issuance of Treasury Shares 4     (3)     7 4  
Stock-based compensation expense 155     155          
Dividends to preferred shareholders     249 (249)          
Transactions with non-controlling interests (1)     2       2 (3)
Ending balance at Dec. 31, 2018 15,794 $ 56   27,210 (5,958) (2,459) (4,142) 14,707 1,087
Ending balance, shares at Dec. 31, 2018   1,196              
Net income (loss) (1,000)       (999)     (999) (2)
Other comprehensive income (loss) 160         147   147 14
Issuance of Shares, shares   2              
Issuance of Treasury Shares 6     (8)     14 6  
Stock-based compensation expense [3] 119     119       119  
Transactions with non-controlling interests (8)               (8)
Other (8)     (8)       (8)  
Ending balance at Dec. 31, 2019 15,063 $ 56   27,312 (6,956) (2,312) (4,128) 13,972 1,091
Ending balance, shares at Dec. 31, 2019   1,198              
Net income (loss) (4,099)       (3,990)     (3,990) (109)
Other comprehensive income (loss) (30)         (86)   (86) 56
Issuance of Shares, value 1             1  
Issuance of Shares, shares [4]   4              
Stock-based compensation expense 129     129       129  
Transactions with non-controlling interests (2)               (2)
Ending balance at Dec. 31, 2020 $ 11,061 $ 57 $ 0 $ 27,443 $ (10,946) $ (2,399) $ (4,128) $ 10,026 $ 1,035
Ending balance, shares at Dec. 31, 2020   1,202              
[1] Mandatory convertible preferred shares.
[2] Following the adoption of ASU 2016-01, the Company recorded a $ 5 million opening balance reclassification from accumulated other comprehensive income to retained earnings.
[3] Mainly MCPS conversion.
[4] Represents an amount less than 0.5 million.